Retatrutide: Surgery-Level Results from a Triple Agonist The most striking data to emerge from the GLP-1 drug pipeline in 2026 comes from retatrutide, Eli Lillys investigational first-in-class triple hormone receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously

Key Research Features Mitochondrial-encoded peptide rare non-nuclear origin 16-amino acid sequence, ~1.7 kDa AMPK pathway activation in experimental models Reported mitochondrial-to-nuclear translocation under metabolic stress 99% HPLC-verified purity Lyophilized powder format Soluble in sterile water or PBS Suitable for in vitro and preclinical research Batch-tested for consistency Research-grade manufacturing standards Professionally labeled and documented Storage Recommendations To maintain product stability and research integrity, MOTS-c should be: Stored at 20C in a tightly sealed container Protected from light and moisture Kept sealed until use Handled according to standard laboratory procedures Not subjected to repeated freeze-thaw cycles Toxicology and Regulatory Information Evaluated in preclinical metabolic, aging, and mitochondrial signaling research models Endogenous peptide levels reported to decline naturally with age in both animal and human tissue samples No FDA-approved MOTS-c drug or therapeutic product exists Supplied strictly as a Research Use Only (RUO) material Why Choose Summit Pep Labs

Standard L-carnitine is also suitable if youre seeking a supplement that promotes heart health and supports cellular energy across the board
These receptors are distributed throughout the body, including the brain [29, 30]
Tirzepatide The 2 medications we offer at our chiropractic center are semaglutide and tirzepatide